We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9602:TSEToho Co., Ltd. Analysis

Data as of 2026-06-13 - not real-time

SAR 9.24

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its short‑term moving average while also under the longer‑term average, reinforcing bearish momentum. The 14‑day RSI sits near the midpoint, indicating neither overbought nor oversold conditions. MACD shows a slight bullish histogram despite the line remaining negative, suggesting limited short‑term upside potential. Price is hovering near a well‑defined support level, with resistance only a modest distance away. Volume has been trending lower, which diminishes the conviction behind any breakout. Overall technicals point to a cautious stance with limited upside in the near term.
Fundamentally, the company posted a sharp decline in revenue and continues to generate negative operating margins, highlighting operational challenges. Profitability is thin, and cash flow from operations is negative, raising concerns about sustainable earnings. The price‑to‑earnings multiple is markedly higher than the industry average, implying that the stock is priced for strong growth that is not evident in the financials. With no dividend and a low payout capacity, income‑focused investors have little appeal. The beta is low, indicating limited market‑wide volatility, yet the stock’s own price volatility is elevated, adding to risk. Given the bearish technical picture, high valuation, and weak fundamentals, the outlook remains tentative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • bearish price trend with price below short‑term moving average
  • proximity to support and limited upside
  • decreasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • significant revenue decline and negative operating margins
  • valuation far above industry peers
  • absence of dividend and weak cash flow

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • potential for strategic restructuring in asset‑management segment
  • low beta suggesting limited systematic risk
  • high price volatility and liquidity constraints

Key Metrics & Analysis

Financial Health

Revenue Growth-48.10%
Profit Margin6.99%
P/E Ratio46.2
ROE1.81%
ROA1.57%
Debt/Equity1.88
P/B Ratio0.8
Op. Cash FlowSAR-35205000
Industry P/E16.8

Technical Analysis

TrendBearish
RSI47.1
SupportSAR 8.94
ResistanceSAR 9.46
MA 20SAR 9.26
MA 50SAR 9.36
MA 200SAR 10.02
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.32
Volatility23.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.